Clinical Trial Update: Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics [NA]

View source ↗

Summary

A completed clinical trial comparing the safety and performance of TAXUS Element against XIENCE Prime stents in diabetic patients with coronary lesions. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• TAXUS Element Stent
• Xience Prime Stent (everolimus-eluting stent)

Snippet

Sponsor: Fortis Escorts Heart Institute | Conditions: Type 2 Diabetes, Coronary Heart Disease | NA | Status: COMPLETED